Skeletal effects and functional outcome with olpadronate in children with osteogenesis imperfecta: a 2-year randomised placebo-controlled study
Authors:
- Ralph SakkersRSRalph Sakkers
- Dieke KokDKDieke Kok
- Raoul EngelbertRERaoul Engelbert
- Alice van DongenADAlice van Dongen
- Maarten JansenMJMaarten Jansen
- Hans PruijsHPHans Pruijs
- Ab VerboutAVAb Verbout
- Dave SchweitzerDSDave Schweitzer
- Cuno UiterwaalCUCuno Uiterwaal
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 363 (9419) , 1427-1431
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Do Bisphosphonates Make Children's Bones Better or Brittle?New England Journal of Medicine, 2003
- Bisphosphonate-Induced OsteopetrosisNew England Journal of Medicine, 2003
- Bone Mass, Size, and Density in Children and Adolescents With Osteogenesis Imperfecta: Effect of Intravenous Pamidronate TherapyJournal of Bone and Mineral Research, 2003
- Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfectaArchives of Disease in Childhood, 2002
- Efficacy of Low Dose Schedule Pamidronate Infusion in Children with Osteogenesis ImperfectaJournal of Pediatric Endocrinology and Metabolism, 2001
- Osteogenesis imperfecta in childhood: Impairment and disability—A follow-up studyArchives of Physical Medicine and Rehabilitation, 1999
- Cyclic Administration of Pamidronate in Children with Severe Osteogenesis ImperfectaNew England Journal of Medicine, 1998
- Mineralisation defects with pamidronate therapy for Paget's diseaseThe Lancet, 1993
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982
- Nonoperative Treatment of Osteogenesis ImperfectaClinical Orthopaedics and Related Research, 1981